Regulatory exclusivities (New Chemical Entity exclusivity, Orphan Drug Exclusivity, pediatric exclusivity) are wholly separate from patents and are often the last line of defense when a CoM patent is invalidated
Genetic factors, metabolism, and baseline weight significantly influence whether 1 mg, 1.7 mg, or the full 2.4 mg dose delivers your best results
The side effects were minor and didnt disrupt her daily life
Cognitive & Neuroprotective Effects This is an emerging but genuinely interesting area of GHK-Cu research
Three diabetes incretin medications are now approved for pediatric use starting at age 10 (see cheat sheet), and two incretin-based weight management medications are approved for children aged 12 and older
Fact: What you eat still matters